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ABSTRACT
An endophytic fungus isolated from the small palm Asterogyne martiana produced two unusual steroid-like metabolites, asterogynin A (1) and
asterogynin B (2), along with the known compounds viridiol (3) and viridin (4). Asterogynins A and B were characterized by NMR and MS
spectroscopic analysis.
Fungi have made noteworthy contributions to our store of
naturally occurring small molecules as they have contributed
more than a quarter by most reckonings, and these contribu-
tions have come from only a tiny fraction of the world’s
estimated 1.5 million fungal species. Only ∼5% of the fungal
species have been scientiﬁcally studied, and a minority of
these have been studied chemically.
1-3 The endophytic fungi
that live inside of vascular plants constitute one of the richest
sources of poorly examined fungi. As part of a longstanding
collaborative research project with INBio (National Biodi-
versity Institute), we have begun characterizing some of the
chemical diversity of Costa Rican endophytes. Costa Rica’s
location on the slender land bridge between North and South
American organisms makes it a natural mixing bowl for the
organisms of both continents. As a result, the country’s many
different ecological niches contain over 9000 species of
vascular plants.
In one recent project, extracts from Costa Rican endo-
phytes were screened for their ability to bind PfHsp86, an
essential protein-folding chaperone from Plasmodium falci-
parum, the parasite responsible for the most deadly form of
human malaria. Plasmodium falciparum encodes three full-
length Hsp90 genes for the proteins PfHsp86, PfGRP94, and
PfTRAP1. PfHsp86 has 59% amino acid identity with human
Hsp90R2, and its highly conserved ATP-binding Bergerat
fold has 75% identity. PfHsp86 could be a drug target for
malaria as the Plasmodium parasites transition between cold-
blooded mosquito vectors and warm-blooded and often
febrile human hosts, a transition that should create a
substantial requirement for assisted protein folding.
4 Some
known human Hsp90 inhibitors, like geldanamycin, inhibit
parasite growth through PfHsp86 inhibition.
4
The dichloromethane extract of CR1488E, which was
isolated from the host plant Asterogyne martiana (Arecaceae)
and whose closest relative based on DNA sequencing is
Chalara alabamensis, was active with an EC50 value of ∼24
µg/mL. Here we report the isolation and structure elucidation
of asterogynins A (1)a n dB( 2) from CR1488E.
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by C-18 prep-HPLC to yield compounds 1, 2, 3, and 4.
Compounds 3 and 4 were identiﬁed as the known natural
products viridiol
5 and viridin,
6 respectively. The viridin class
of steroidal furans contains potent antifungal agents and
covalent inhibitors of phosphatidylinositol 3-kinase (PI3
kinase) and polo-like kinase.
7 As viridin-like compounds
react with the ATP-binding site of kinases, it is likely that
they could also bind the ATP pocket of chaperone and other
proteins.
The 1H NMR spectrum of 1
8 in CD3OD showed two
aromatic protons and one oleﬁnic proton, one methoxy, three
methylenes, and one methyl group. The 13C NMR spectrum
exhibited 18 signals, including three carbonyls, six aromatic
carbons, one double bond, two quaternary and three second-
ary carbons, one methoxy, and one methyl group. These
assignments were further conﬁrmed by the HSQC spectrum.
The HRMS (positive-ion mode) had an ion peak at m/z
295.0969, consistent with a molecular composition of
C18H15O4 ([M - H2O + H], calcd 295.0970), a molecular
formula that required 11 double-bond equivalents. Besides
three carbonyls, one double bond, and an aromatic ring, there
must be three more rings in the molecule. In the COSY
spectrum of 1, two cross-peaks from two coupling systems
[CHdCH (aromatic: δH 7.78, d, J ) 8.0 Hz, H-11; 8.01, d,
J ) 8.0 Hz, H-12) and CH2-CH2 (δH 3.37, m, H-15; 2.74,
m, H-16)] were observed. Rings C and D were readily
established from the HMBC correlations between the car-
bonyl at ring D and one aromatic proton and the two coupling
methylenes. The 13C chemical shifts of the carbons in rings
Ca n dD( δc 130.6, C-8; 166.1, C-9; 131.6, C-11; 124.8,
C-12; 139.0, C-13; 156.8, C-14; 25.3, C-15; 37.0, C-16;
207.9, C-17) matched those of demethoxyviridin and its
analogues
9 very well, which further conﬁrmed these two
rings. The carbonyl in ring A (δc 192.5, C-3) had to be an
R, -unsaturated ketone (δc 120.7, C-1; 150.5, C-2) since its
13C chemical shift was <195 ppm, and the oleﬁnic proton
(δH 6.05, s, H-1) showed a strong HMBC correlation to that
carbonyl carbon. In the HMBC spectrum (Figure 1), the
methyl group (δH 1.54, s, H3-19) had correlations with the
protonated oleﬁnic carbon at δc 120.7 (C-1), which indicated
that it must be at the  -position of the R, -unsaturated ketone,
one aromatic carbon (δc 166.1, C-9), and two quaternary
carbons (δc 49.0, C-10; 82.5, C-5), one of which was
oxygenated. Although no HMBC correlations in CD3OD
between the third methylene and any carbon was observed,
rings A and B were deduced to be six- and ﬁve-membered
rings, respectively, with the oxygenated quaternary carbon
connected to the methylene (δc 44.5, C-4) at ring A and
carbonyl (δc 204.2, C-7) at ring B. To check this, both HSQC
and HMBC spectra of compound 1 were collected in C6D5N,
and correlations between the methylene at ring A and C-2,
C-3, C-5, C-7, and C-10 were observed. In the ROESY
spectrum of 1 in C6D5N, H3-19 showed correlation to 5-OH
(Figure 2), indicating a cis relationship between these two
functional groups. Hence, the structure of 1 was determined
as shown.
Compound 2
10 had a molecular formula of C18H16O4. The
only difference between 1 and 2 was the substituent at C-5.
In the HMBC spectrum of 2, the methyl group had
correlations to the protonated oleﬁnic carbon, one aromatic
carbon and the quaternary carbon, and the tertiary carbon,
indicating a methine at the 5 position. No ROESY cross-
peak between H3-19 and 5-H was observed. Hence, the
structure of 2 was determined as shown.
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(10) Asterogynin B (2): colorless powder; [R]26
D +46 (c, 0.03 MeOH);
UV (MeOH) λmax (log e) 235, 312 nm; 1H NMR (600 MHz, CD3OD) d
1.84 s (H3-19), 2.14 and 3.29 m (H2-4), 3.31 and 3.40 m (H2-15), 3.45 s
(-OMe), 5.91 s (H-2), 7.80 d, J ) 7.8 Hz (H-11), 8.03 d, J ) 7.8 Hz
(H-12); 13C NMR (150 MHz, CD3OD) d 24.5 (C-19), 25.4 (C-15), 36.4
(C-16), 38.9 (C-4), 45.6 (C-10), 55.2 (OMe), 53.3 (C-5), 123.3 (C-1), 124.0
(C-12), 130.8 (C-8), 132.6 (C-11), 138.6 (C-13), 149.8 (C-2), 156.0 (C-
14), 168.1 (C-9), 192.4 (C-3), 207.8 (C-17); HRMS m/z 297.1123 (calcd
for C18H17O4, 297.1127).
Figure 1. Key HMBC (arrows) and COSY (dashed curves)
correlation of (1).
4662 Org. Lett., Vol. 12, No. 20, 2010Because of their overall structure and association with
viridin (4) and viridiol (3), asterogynins A (1)a n dB( 2) are
likely sterol derivatives with a tetracyclic (6-5-6-5)
carbocyclic ring system, which differs from the tetracyclic
(6-6-6-5) of 3, 4, and other steroids. Only a few
B-norsteroids (5 is typical)
11 with more complex structures
have been previously reported from other sources. The
asterogynins A (1)a n dB( 2) are quite different in having
no remnants of the typical steroid side chain. They also lack
the furan ring of 3 and 4. Viridin (4) is a modiﬁed steroid,
12
and it is therefore likely that asterogynins A (1)a n dB( 2)
are also derived from the steroidal pathway. Whether they
are further elaborations of viridin/viridiol through oxidative
removal of the furan ring or arise from a separate pathway
is not clear.
All four compounds were tested against PfHsp86, but only
compound 3 was active with an EC50 value of 5.5 ( 1.2
µg/mL. Further biological evaluations of compounds 1 and
2 are now being conducted and will be reported in due
course.
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Figure 2. Key ROESY correlation of 1.
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